The global microfluidics prototype market is expected to witness a notable growth in the upcoming years. R&D tools and reasonable business innovations significantly fuel the development. Launch of trend-setting innovations, surging demand for low volume sample, and the rise of 3D printing innovation are foreseen to propel growth in global microfluidics prototype market.
Companies operating in the global Microfluidics Market are focusing on merger and acquisitions and new product launches to gain competitive advantage. Growth strategies adopted by these companies are studied in detail in the report. The report also includes several valuable information on the Microfluidics Market, derived from various industrial sources.
The global microfluidics market was valued at USD 4.552 billion in 2017, and is expected to reach USD 111.95 billion by 2023, recording a CAGR of 17.45% over the forecast period of 2018-2023. The scope of the report is limited to solutions offered by major players, including providers of microfluidic chips, micro pumps, and micro needles. The regions considered in the scope of the report include North America, Europe, Asia-Pacific, and rest of the world.
Microfluidics Market by Companies:
Danaher Corporation, PerkinElmer Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., uFluidix, Dolomite Centre, F. Hoffmann-La Roche AG, Fluidigm Corporation, Micronit Microfluidics BV, Abbott Laboratories.